Login / Signup

Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study.

Marina SerperDavid E KaplanTamar H TaddeiElliot B TapperJordana B CohenNadim Mahmud
Published in: Hepatology (Baltimore, Md.) (2022)
There is an ongoing need to noninvasively identify patients who may benefit from NSBBs for the prevention of hepatic decompensation.
Keyphrases
  • cardiovascular events
  • quality improvement
  • risk factors
  • angiotensin converting enzyme
  • type diabetes
  • cardiovascular disease
  • angiotensin ii